InvestorsObserver
×
News Home

Is VBI Vaccines Inc (VBIV) Stock Worth a Buy Wednesday?

Wednesday, June 22, 2022 02:29 PM | InvestorsObserver Analysts

Mentioned in this article

Is VBI Vaccines Inc (VBIV) Stock Worth a Buy Wednesday?

VBI Vaccines Inc (VBIV) stock is lower by -76.35% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives VBIV stock a score of 28 out of a possible 100.

That rank is influenced by a short-term technical score of 2. VBIV's rank also includes a long-term technical score of 18.
Overall Score - 28
VBIV has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on VBIV!

What's Happening with VBIV Stock Today

VBI Vaccines Inc (VBIV) stock has risen 19.63% while the S&P 500 has gained 0.73% as of 2:28 PM on Wednesday, Jun 22. VBIV has gained $0.15 from the previous closing price of $0.77 on volume of 5,292,062 shares. Over the past year the S&P 500 has fallen -10.70% while VBIV is lower by -76.35%. VBIV lost -$0.29 per share in the over the last 12 months. Click Here to get the full Stock Report for VBI Vaccines Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App